Carlson Capital Management Pfizer Inc Transaction History

Carlson Capital Management

$1.26 Billion
Q2 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 16, 2024	SELL	$26.13 - $33.94 $126,861 - $164,778	-4,855 Reduced 35.88%	8,678 $249,000
Q3 2023 Nov 21, 2023	SELL	$32.09 - $37.51 $5,551 - $6,489	-173 Reduced 1.26%	13,533 $448,000
Q2 2023 Jul 24, 2023	SELL	$36.12 - $41.79 $66,677 - $77,144	-1,846 Reduced 11.87%	13,706 $502,000
Q1 2023 Apr 17, 2023	SELL	$39.39 - $51.28 $17,567 - $22,870	-446 Reduced 2.79%	15,552 $634,000
Q4 2022 Feb 03, 2023	SELL	$41.75 - $54.5 $48,805 - $63,710	-1,169 Reduced 6.81%	15,998 $820,000
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $51,811 - $63,249	-1,184 Reduced 6.45%	17,167 $751,000
Q2 2022 Jul 18, 2022	SELL	$46.53 - $55.17 $42,109 - $49,928	-905 Reduced 4.7%	18,351 $962,000
Q1 2022 May 24, 2022	BUY	$45.75 - $56.69 $12,352 - $15,306	270 Added 1.42%	19,256 $997,000
Q4 2021 Jan 14, 2022	BUY	$41.32 - $61.25 $47,807 - $70,866	1,157 Added 6.49%	18,986 $1.12 Million
Q3 2021 Oct 12, 2021	BUY	$39.25 - $50.42 $20,645 - $26,520	526 Added 3.04%	17,829 $767,000
Q2 2021 Jul 12, 2021	BUY	$35.91 - $40.68 $52,787 - $59,799	1,470 Added 9.28%	17,303 $678,000
Q1 2021 Apr 12, 2021	BUY	$33.49 - $37.77 $2,846 - $3,210	85 Added 0.54%	15,833 $574,000
Q4 2020 Jan 11, 2021	BUY	$33.47 - $42.56 $23,127 - $29,408	691 Added 4.59%	15,748 $585,000
Q3 2020 Oct 13, 2020	BUY	$31.75 - $37.25 $19,970 - $23,430	629 Added 4.36%	15,057 $553,000
Q2 2020 Jul 13, 2020	BUY	$30.12 - $36.54 $62,589 - $75,930	2,078 Added 16.83%	14,428 $488,000
Q1 2020 Apr 27, 2020	BUY	$27.03 - $38.62 $44,653 - $63,800	1,652 Added 15.44%	12,350 $462,000
Q4 2019 Jan 27, 2020	BUY	$32.92 - $37.36 $26,862 - $30,485	816 Added 8.26%	10,698 $419,000
Q3 2019 Oct 29, 2019	BUY	$32.49 - $42.13 $8,349 - $10,827	257 Added 2.67%	9,882 $355,000
Q1 2019 Apr 25, 2019	BUY	$37.5 - $41.2 $22,875 - $25,132	610 Added 6.77%	9,625 $409,000
Q4 2018 Jan 22, 2019	BUY	$38.47 - $43.86 $14,734 - $16,798	383 Added 4.44%	9,015 $394,000
Q3 2018 Oct 19, 2018	BUY	$34.47 - $41.81 $9,651 - $11,706	280 Added 3.35%	8,632 $380,000
Q2 2018 Jul 26, 2018	SELL	$32.98 - $35.16 $10,190 - $10,864	-309 Reduced 3.57%	8,352 $303,000
Q1 2018 Apr 20, 2018	SELL	$31.91 - $37.02 $44,035 - $51,087	-1,380 Reduced 13.74%	8,661 $307,000
Q4 2017 Jan 08, 2018	SELL	$33.26 - $35.29 $266 - $282	-8 Reduced 0.08%	10,041 $364,000
Q3 2017 Oct 16, 2017	BUY	$31.0 - $34.15 $311,519 - $343,173	10,049	10,049 $359,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.73B

Call Options Held

73.5M

Put Options Held

108M

Vanguard Group Inc Valley Forge, PA

511M
Shares

$13.4 Billion
0.28% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$11.1 Billion
0.27% of portfolio
State Street Corp Boston, MA

287M
Shares

$7.53 Billion
0.36% of portfolio
Wellington Management Group LLP Boston, MA

166M
Shares

$4.36 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

130M
Shares

$3.41 Billion
0.73% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $147B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Carlson Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Carlson Capital Management with notifications on news.

Account